ImmunoClear is the only liquid biopsy method that includes plasma cell-free RNA (cfRNA) PD-L1 testing. PD-L1 expression has been correlated with clinical effectiveness and improved survival rates when treated with immunotherapy. ImmunoClear has been demonstrated to be predictive of significant survival benefits of immunotherapy treatment over chemotherapy in advanced non-small cell lung cancer (NSCLC) patients. 

## Unique cfRNA PD-L1 Testing 

Offers a novel method to assess PD-L1 expression, providing crucial insights into immunotherapy response.



## Proven Predictive Value 

Clinical studies show that ImmunoClear predicts significant survival benefits for NSCLC patients receiving immunotherapy over chemotherapy.



## Enhanced Immunotherapy Guidance 

Helps physicians determine which patients will benefit most from immunotherapy.

ImmunoClear is the only liquid biopsy method that includes plasma cell-free RNA (cfRNA) PD-L1 testing. PD-L1 expression has been correlated with clinical effectiveness and improved survival rates when treated with immunotherapy. ImmunoClear has been demonstrated to be predictive of significant survival benefits of immunotherapy treatment over chemotherapy in advanced non-small cell lung cancer (NSCLC) patients. 

ImmunoClear

CIRCULOGENE is a molecular diagnostics company specializing in liquid biopsy technologies to detect clinically significant tumor DNA and RNA alterations. Since its inception in 2015, the company has provided innovative, non-invasive testing solutions to over 25,000 cancer patients, aiding oncologists in personalizing and monitoring treatment plans for improved patient outcomes.{class="lead"}

Headquartered in Birmingham, Alabama, with laboratories in Pensacola and West Palm Beach, Florida, CIRCULOGENE combines patented methodologies with advanced technologies to offer a comprehensive suite of testing services.

SDV Medical is a proud partner and distributor of CIRCULOGENE's innovative Liquid biopsy systems because we believe in making a difference for patients and healthcare providers alike. Our values align with CIRCULOGENE’s commitment to advancing cancer care, particularly in the context of veteran health at Veterans Association Hospitals. CIRCULOGENE's commitment to innovation and patient care is evident in its comprehensive testing solutions, providing actionable insights to personalize and improve cancer treatment strategies

SDV Medical offers a variety of cutting-edge CIRCULOGENE products in our catalog. Our flagship offerings from CIRCULOGENE are:

ImmunoClear

Unique cfRNA PD-L1 Testing

Proven Predictive Value

Enhanced Immunotherapy Guidance

Contact sales to plan for the acquisition of this equipment.